Literature DB >> 17344846

Patterns of somatic mutation in human cancer genomes.

Christopher Greenman1, Philip Stephens, Raffaella Smith, Gillian L Dalgliesh, Christopher Hunter, Graham Bignell, Helen Davies, Jon Teague, Adam Butler, Claire Stevens, Sarah Edkins, Sarah O'Meara, Imre Vastrik, Esther E Schmidt, Tim Avis, Syd Barthorpe, Gurpreet Bhamra, Gemma Buck, Bhudipa Choudhury, Jody Clements, Jennifer Cole, Ed Dicks, Simon Forbes, Kris Gray, Kelly Halliday, Rachel Harrison, Katy Hills, Jon Hinton, Andy Jenkinson, David Jones, Andy Menzies, Tatiana Mironenko, Janet Perry, Keiran Raine, Dave Richardson, Rebecca Shepherd, Alexandra Small, Calli Tofts, Jennifer Varian, Tony Webb, Sofie West, Sara Widaa, Andy Yates, Daniel P Cahill, David N Louis, Peter Goldstraw, Andrew G Nicholson, Francis Brasseur, Leendert Looijenga, Barbara L Weber, Yoke-Eng Chiew, Anna DeFazio, Mel F Greaves, Anthony R Green, Peter Campbell, Ewan Birney, Douglas F Easton, Georgia Chenevix-Trench, Min-Han Tan, Sok Kean Khoo, Bin Tean Teh, Siu Tsan Yuen, Suet Yi Leung, Richard Wooster, P Andrew Futreal, Michael R Stratton.   

Abstract

Cancers arise owing to mutations in a subset of genes that confer growth advantage. The availability of the human genome sequence led us to propose that systematic resequencing of cancer genomes for mutations would lead to the discovery of many additional cancer genes. Here we report more than 1,000 somatic mutations found in 274 megabases (Mb) of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers. There was substantial variation in the number and pattern of mutations in individual cancers reflecting different exposures, DNA repair defects and cellular origins. Most somatic mutations are likely to be 'passengers' that do not contribute to oncogenesis. However, there was evidence for 'driver' mutations contributing to the development of the cancers studied in approximately 120 genes. Systematic sequencing of cancer genomes therefore reveals the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344846      PMCID: PMC2712719          DOI: 10.1038/nature05610

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  39 in total

1.  Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

Authors:  D Cappellen; C De Oliveira; D Ricol; S de Medina; J Bourdin; X Sastre-Garau; D Chopin; J P Thiery; F Radvanyi
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

2.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

3.  A codon-based model of nucleotide substitution for protein-coding DNA sequences.

Authors:  N Goldman; Z Yang
Journal:  Mol Biol Evol       Date:  1994-09       Impact factor: 16.240

4.  Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.

Authors:  D H Teng; W L Perry; J K Hogan; M Baumgard; R Bell; S Berry; T Davis; D Frank; C Frye; T Hattier; R Hu; S Jammulapati; T Janecki; A Leavitt; J T Mitchell; R Pero; D Sexton; M Schroeder; P H Su; B Swedlund; J M Kyriakis; J Avruch; P Bartel; A K Wong; S V Tavtigian
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

5.  Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.

Authors:  G H Su; W Hilgers; M C Shekher; D J Tang; C J Yeo; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1998-06-01       Impact factor: 12.701

Review 6.  Human mismatch repair, drug-induced DNA damage, and secondary cancer.

Authors:  Peter Karran; Judith Offman; Margherita Bignami
Journal:  Biochimie       Date:  2003-11       Impact factor: 4.079

7.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

Authors:  S Markowitz; J Wang; L Myeroff; R Parsons; L Sun; J Lutterbaugh; R S Fan; E Zborowska; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

Review 8.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

Review 9.  Targeted cancer therapy.

Authors:  Charles Sawyers
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Human autoantibodies reveal titin as a chromosomal protein.

Authors:  C Machado; C E Sunkel; D J Andrew
Journal:  J Cell Biol       Date:  1998-04-20       Impact factor: 10.539

View more
  1270 in total

Review 1.  Catalytic mechanisms and regulation of protein kinases.

Authors:  Zhihong Wang; Philip A Cole
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 2.  IκB kinase alpha and cancer.

Authors:  Shuang Liu; Zhisong Chen; Feng Zhu; Yinling Hu
Journal:  J Interferon Cytokine Res       Date:  2011-12-07       Impact factor: 2.607

Review 3.  Practicing pathology in the era of big data and personalized medicine.

Authors:  Jiang Gu; Clive R Taylor
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

Review 4.  An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.

Authors:  R G Bristow; A Berlin; A Dal Pra
Journal:  Br J Radiol       Date:  2014-02-03       Impact factor: 3.039

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.

Authors:  Jin Li; Lilin Wang; Pasi A Jänne; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2009-02-20       Impact factor: 8.327

Review 7.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next-generation sequencing.

Authors:  Asahiro Morishita; Hisakazu Iwama; Shintaro Fujihara; Miwako Watanabe; Koji Fujita; Tomoko Tadokoro; Kyoko Ohura; Taiga Chiyo; Teppei Sakamoto; Shima Mimura; Takako Nomura; Joji Tani; Hirohito Yoneyama; Keiichi Okano; Yasuyuki Suzuki; Takashi Himoto; Tsutomu Masaki
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

9.  Antagonism between Hedgehog and Wnt signaling pathways regulates tumorigenicity.

Authors:  Mei Ding; Xin Wang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

10.  Quantitative proteome profiling of lymph node-positive vs. -negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis.

Authors:  Roland S Croner; Michael Stürzl; Tilman T Rau; Gergana Metodieva; Carol I Geppert; Elisabeth Naschberger; Berthold Lausen; Metodi V Metodiev
Journal:  Int J Cancer       Date:  2014-05-12       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.